Register entryShortage reported
Medexus Pharma, Inc.
- Registered sites
- 0
- Drug products
- 18
- Live patents
- 12
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Alert
Products in shortage
1| Drug | Presentation | Availability |
|---|---|---|
| Triamcinolone Hexacetonide Injection | Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01) | Unavailable |
Exclusivity
Patents
12Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| GRAFAPEX | TREOSULFAN | Oct 2026 |
| RASUVO | METHOTREXATE | Jun 2029 |
Catalogue
Marketed products
18Showing 18 of 18.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| GRAFAPEX | treosulfan | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| GRAFAPEX | treosulfan | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| Hexatrione 2% | triamcinolone hexacetonide | INJECTION, SUSPENSION | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Ixinity | coagulation factor IX (recombinant) | KIT | BLA |
| Ixinity | coagulation factor IX (recombinant) | KIT | BLA |
| Ixinity | coagulation factor IX (recombinant) | KIT | BLA |
| Ixinity | coagulation factor IX (recombinant) | KIT | BLA |
| Ixinity | coagulation factor IX (recombinant) | KIT | BLA |
| Ixinity | coagulation factor IX (recombinant) | KIT | BLA |
| Rasuvo | methotrexate | INJECTION, SOLUTION | NDA |
| Rasuvo | methotrexate | INJECTION, SOLUTION | NDA |
| Rasuvo | methotrexate | INJECTION, SOLUTION | NDA |
| Rasuvo | methotrexate | INJECTION, SOLUTION | NDA |
| Rasuvo | methotrexate | INJECTION, SOLUTION | NDA |
| Rasuvo | methotrexate | INJECTION, SOLUTION | NDA |
| Rasuvo | methotrexate | INJECTION, SOLUTION | NDA |
| Rasuvo | methotrexate | INJECTION, SOLUTION | NDA |
| Rasuvo | methotrexate | INJECTION, SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.